Drug delivery with a purpose

Recovery deserves
a new direction.

Developing non-opioid approaches to acute pain, with drug delivery science at the center.

Explore the science
Scientist examining a test tube, official Rebel Medicine photography
A different point of view

The days after surgery matter.
That is where our work begins.

Alevatrix™ is an investigational extended-release bupivacaine gel being developed for postoperative pain
Our lead program

An injectable gel.
A considered ambition.

Alevatrix™ is an investigational extended-release bupivacaine gel being developed for postoperative pain. Its intended format is a ready-to-use prefilled syringe.

Inside the pipeline
Contextual photograph of a laboratory scientist, not Rebel Medicine staff
A closer perspective

A shared problem. Many disciplines.

Engineering × medicine

Built at the intersection.
Focused on recovery.

Brett Davis, Rebel Medicine co-founder and CEO

Biomedical engineers, physicians and entrepreneurs bring different perspectives to the same challenge: developing more useful ways to manage acute pain.

Meet the people
Find your way

A conversation
worth starting.

Contextual photograph of medical research; not client staff
01 / Your next step

Advance an ambitious program.

Explore development and collaboration opportunities with the company’s business development team.

Explore partnering

Let’s move
the work forward.

Start with a focused conversation about the science and the opportunity.

Connect with Rebel